AOD-9604 101: A Plain-English Guide for 2026

AOD-9604 at a glance:

• Drug class: Metabolic / longevity research peptide
• Route: subcutaneous injection in research
• Typical frequency: no established human regimen
• Half-life: typically short systemically

If you're trying to figure out whether AOD-9604 is right for you — or for someone you care about — the right starting point is the basic biology. AOD-9604 is a metabolic / longevity research peptide. Improvements in insulin sensitivity, exercise capacity, or markers of cellular aging in animal models.

What is AOD-9604?

These peptides target mitochondrial function, AMPK signaling, or other metabolic pathways implicated in aging and metabolic disease. Most evidence is preclinical.

There is no single FDA-licensed manufacturer of AOD-9604 for human therapeutic use. Material in the research and grey markets is supplied by various unregulated sources, which raises real questions about purity and dosing accuracy. AOD-9604 is not currently approved by the FDA for general human use. Available evidence comes from animal and cell-culture studies. We do not endorse self-administration of unapproved compounds.

The drug class metabolic / longevity research peptide works by targeting specific receptor pathways. Here's how that breaks down.

How AOD-9604 Works in the Body

These peptides target mitochondrial function, AMPK signaling, or other metabolic pathways implicated in aging and metabolic disease. Most evidence is preclinical. The receptor target — compound-specific — drives the downstream effects users care about: improvements in insulin sensitivity, exercise capacity, or markers of cellular aging in animal models.

The pharmacokinetics matter for daily use. AOD-9604 has a half-life of typically short systemically, which determines how often it is dosed. The standard route of administration is subcutaneous injection in research, and the typical schedule is no established human regimen.

For more detail on the underlying biology, see our breakdown of how AOD-9604 works.

Who Uses AOD-9604?

AOD-9604 is most relevant for people whose situation maps to its approved indications: none currently approved.

People who should avoid AOD-9604 include those with the following:

• allergy to the active ingredient or any excipient
• pregnancy or breastfeeding (per label)
• conditions specifically called out in the prescribing information

Common and Serious Side Effects

The most commonly reported side effects of AOD-9604 include:

• limited human data

Serious risks — uncommon but worth knowing — include:

• unknown long-term effects

We have a more detailed breakdown in our AOD-9604 side-effects guide.

AOD-9604 vs Alternatives

Evidence-based metabolic therapies include metformin, GLP-1 agonists, and lifestyle interventions. If you are weighing AOD-9604 against another option, our comparison pages include AOD-9604 Side Effects Decoded: What's Normal vs. What Isn't, Real AOD-9604 Results: What 6 and 12 Months Actually Look Like, AOD-9604 Price Decoded: Insurance, Coupons, and Cash-Pay Options.

Bottom Line

AOD-9604 delivers what its label says it delivers. The case for it (or against it) comes down to your specific situation, not abstract comparisons. Evidence remains preliminary; we recommend caution and clinician oversight. If you are considering AOD-9604, talk to a licensed clinician first — particularly if you take other medications.

Frequently Asked Questions

Related Reading

• AOD-9604 Side Effects Decoded: What's Normal vs. What Isn't
• Real AOD-9604 Results: What 6 and 12 Months Actually Look Like
• AOD-9604 Price Decoded: Insurance, Coupons, and Cash-Pay Options
• AOD-9604 Cycles Explained: Where the Evidence Stops
• NAD+ 101: A Plain-English Guide for 2026
• NAD+ Side Effects Decoded: What's Normal vs. What Isn't

Sources

• Lee C et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis. Cell Metabolism 2015;21:443.
• Birk AV et al. The Mitochondrial-Targeted Peptide SS-31 Selectively Improves Mitochondrial Function. JASN 2013;24:1250.

This page is informational only and is not medical advice. Consult a licensed clinician before starting, stopping, or changing any medication.